NT5E and neoplasm: Very recently, although elevated tumor levels of CD73 have been found in melanoma patients with late-stage disease [45], the expression of CD73 within tumor microenvironment is heterogeneous in primary melanomas and cutaneous melanoma metastases [42], raising the question whether immunohistochemical analysis of CD73 may be a valuable prognostic factor in melanoma.